Ferroptosis Is a Potential Novel Diagnostic and Therapeutic Target for Patients With Cardiomyopathy

Area of Science:

• Biomedical Science
• Cardiovascular Research
• Cell Death Pathways

Background:

• Cardiomyocyte death is central to cardiomyopathy progression, but its triggers remain largely unknown.
• Ferroptosis, an iron-dependent programmed cell death, has recently emerged as a significant biological process.
• Growing evidence links ferroptosis to the pathogenesis of various cardiovascular diseases.

Purpose of the Study:

• To elucidate the mechanism of ferroptosis.
• To review the critical role of ferroptosis in the development of cardiomyopathy.
• To highlight ferroptosis as a potential diagnostic and therapeutic target for cardiomyopathy.

Main Methods:

• Literature review of recent research on ferroptosis and cardiomyopathy.
• Analysis of studies investigating ferroptosis inhibitors, iron chelators, and antioxidants in myocardial injury.
• Examination of animal models of cardiomyopathy to assess the role of ferroptosis.

Main Results:

• Ferroptosis is an iron-dependent, peroxidation-driven cell death pathway.
• Pharmacological inhibition of ferroptosis pathways can mitigate myocardial injury.
• Ferroptosis is recognized as a key cell death mechanism in experimental cardiomyopathy models.

Conclusions:

• Ferroptosis plays a significant role in the pathophysiology of cardiomyopathy.
• Targeting ferroptosis presents a promising avenue for future diagnostic and therapeutic interventions in cardiomyopathy patients.